| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
5 companies
Seidenberg Beth C is a Director at Kyverna Therapeutics, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 11 buys and 5 sells.
Estimated insider holdings value: $15.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | KYTX Kyverna Therapeutics, Inc. | Director | Buy | 133,333 | $7.50 | $999,997.50 | +18.1% | +22.0% | - | |
| Oct 28, 2024 | VERA Vera Therapeutics, Inc. | Director | Sell | 15,000 | $48.03 | $720,493.22 | -5.4% | -26.4% | -36.7% | |
| Sep 19, 2024 | VERA Vera Therapeutics, Inc. | Director | Sell | 16,476 | $42.26 | $696,233.08 | -5.0% | -1.5% | -39.1% | |
| Jul 18, 2023 | SGMT Sagimet Biosciences Inc. | Director | Buy | 46,875 | $16.00 | $750,000.00 | New | -63.0% | -78.7% | |
| Mar 30, 2023 | VERA Vera Therapeutics, Inc. | Director | Buy | 2,300 | $7.24 | $16,650.85 | +0.1% | +139.7% | +479.6% | |
| Mar 28, 2023 | VERA Vera Therapeutics, Inc. | Director | Buy | 23,908 | $7.24 | $173,191.94 | +1.2% | +140.8% | +503.7% | |
| Mar 27, 2023 | VERA Vera Therapeutics, Inc. | Director | Buy | 3,466 | $7.24 | $25,102.11 | - | +139.5% | +469.6% | |
| Mar 20, 2023 | VERA Vera Therapeutics, Inc. | Director | Buy | 89,297 | $7.13 | $636,914.51 | +2.4% | +101.2% | +480.5% | |
| Mar 16, 2023 | VERA Vera Therapeutics, Inc. | Director | Buy | 92,941 | $7.10 | $660,278.24 | +2.6% | +83.9% | +495.7% | |
| Mar 10, 2023 | VERA Vera Therapeutics, Inc. | Director | Buy | 48,003 | $7.16 | $343,485.47 | +2.8% | +18.0% | +501.1% |